Vaccine Therapy in Treating Patients With Recurrent or Persistent Cervical Cancer

Completed · Phase 1

Conditions studied: Cervical Cancer

In brief

RATIONALE: Vaccines may make the body build an immune response to kill tumor cells. PURPOSE: Phase I trial to study the effectiveness of vaccine therapy in treating patients with recurrent or persistent cervical cancer that cannot be treated with surgery or radiation therapy.

Key facts

Study ID

NCT00003977

Run by

Steward St. Elizabeth's Medical Center of Boston, Inc.

Starts

1999-11-01

Last updated by the study team

2009-02-09

Who can join

Age: 18 and older. Sex: female. Healthy volunteers: not accepted.

Where it is running

• St. Elizabeth's Medical Center — Boston, Massachusetts, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.